CORC

在结果中检索

CORC

浏览/检索结果: 共81条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Carbon Ion Radiotherapy Acts as the Optimal Treatment Strategy for Unresectable Liver Cancer During the Coronavirus Disease 2019 Crisis 期刊论文
FRONTIERS IN PUBLIC HEALTH, 2021, 卷号: 9, 页码: 12
作者:  Li, Zheng;  Li, Qiang;  Wang, Xiaohu;  Li, Sha;  Chen, Weiqiang
收藏  |  浏览/下载：24/0  |  提交时间：2022/04/11
Tumor Vessel Targeted Self-Assemble Nanoparticles for Amplification and Prediction of the Embolization Effect in Hepatocellular Carcinoma 期刊论文
ACS NANO, 2020, 卷号: 14, 期号: 11, 页码: 14907-14918
作者:  Wang, Yaqin;  Shang, Wenting;  Zhong, Hongshan;  Luo, Ting;  Niu, Meng
收藏  |  浏览/下载：46/0  |  提交时间：2021/03/01
Identifying optimal candidates for combining transarterial chemoembolization and sorafenib in patients with unresectable hepatocellular carcinoma: A multicenter observational study 期刊论文
JOURNAL OF HEPATOLOGY, 2019, 卷号: 70
作者:  Wang, Enxin;  Bai, Wei;  Wang, Zhexuan;  Xia, Dongdong;  Wang, Qiuhe
收藏  |  浏览/下载：29/0  |  提交时间：2019/12/04
External Radiation versus Internal Radiation for Patients with Advanced Unresectable HCC -A SEER Based Study 期刊论文
JOURNAL OF CANCER, 2019, 卷号: 10, 期号: 5
作者:  Wang, Xuan;  Chen, Mo;  Wei, Ran;  Wang, Zheng
收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05
Evaluation of Targeted Agents for Advanced and Unresectable Hepatocellular Carcinoma: A Network Meta-Analysis 期刊论文
JOURNAL OF CANCER, 2019, 卷号: 10, 期号: 19
作者:  Guo, Tao;  Liu, Pengpeng;  Yang, Jian;  Wu, Ping;  Chen, Baiyang
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
Optimal time-point of response assessment was associated with tumour burden in patients with unresectable hepatocellular carcinoma undergoing repeated transarterial chemoembolization 会议论文
International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), APR 10-14, 2019
作者:  Xia, Dongdong;  Wang, Enxin;  Wang, Qiuhe;  Bai, Wei;  Wang, Zhexuan
收藏  |  浏览/下载：15/0  |  提交时间：2019/12/31
Safety assessment of sorafenib in Chinese patients with unresectable hepatocellular carcinoma: subgroup analysis of the GIDEON study 期刊论文
BMC CANCER, 2018, 卷号: 18
作者:  Ye, Sheng-Long;  Yang, Jiamei;  Bie, Ping;  Zhang, Shuijun;  Chen, Xiaoping
收藏  |  浏览/下载：1/0  |  提交时间：2019/12/05
Phase II Study of Sorafenib Combined with Concurrent Hepatic Arterial Infusion of Oxaliplatin, 5-Fluorouracil and Leucovorin for Unresectable Hepatocellular Carcinoma with Major Portal Vein Thrombosis 期刊论文
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2018, 卷号: 41, 期号: 5
作者:  He, Min-Ke;  Zou, Ru-Hai;  Li, Qi-Jiong;  Zhou, Zhong-Guo;  Shen, Jing-Xian
收藏  |  浏览/下载：40/0  |  提交时间：2019/12/05
Efficacy, safety, and pharmacokinetics of the anti-programmed cell death receptor-1 (PD-1) monoclonal antibody, tislelizumab (BGB-A317) in a phase 2, open-label, multicenter study to investigate in patients with unresectable hepatocellular carcinoma - Trial in progress 会议论文
作者:  Ren, Z.;  Assenat, E.;  Cubillo, A.;  Pluntke, S.;  Rimassa, L.
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05
Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy for Unresectable Hepatitis B Virus-related Hepatocellular Carcinoma: A Single Center Study of 45 Patients. 期刊论文
Annals of surgery, 2018
作者:  Wang Zheng;  Peng Yuanfei;  Hu Jingwu;  Wang Xiaoying;  Sun Huichuan
收藏  |  浏览/下载：14/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace